Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton - PubMed (original) (raw)
Comparative Study
. 1996 Aug;73(4):1091-107.
doi: 10.1016/0306-4522(96)00106-6.
Affiliations
- PMID: 8809827
- DOI: 10.1016/0306-4522(96)00106-6
Comparative Study
Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton
C Nolte et al. Neuroscience. 1996 Aug.
Abstract
Microglial cells respond to most pathological events by rapid transformation from a quiescent to an activated phenotype characterized by increased cytotoxicity and motile activity. To investigate the regulation of microglial motility by different inflammatory mediators, we studied cultured murine microglia by time-lapse video microscopy and a computer-based motility assay. Microglial cells exhibited a high resting motility. The acute application of complement 5a (C5a) immediately induced intense ruffling of microglial membranes followed by lamellipodia extension within few seconds, while formyl-Met-Leu-Phe-OH, bacterial endotoxin (lipopolysaccharide) or inflammatory cytokines did not increase motility. This process was accompanied by a rapid rearrangement of the actin cytoskeleton as demonstrated by labelling with fluorescein isothiocyanate-phalloidin and could be inhibited by cytochalasin B. A GTP-binding protein was involved in the signal cascade, since pertussis toxin inhibited motility and actin assembly in response to C5a. Chemotactic migration in a gradient of C5a was also completely blocked by pertussis toxin and cytochalasin B. The C5a-induced motility reaction was accompanied by an increase in intracellular calcium ([Ca2+]i) as measured by a Fluo-3 based imaging system. Ca2+ transients were, however, not a prerequisite for triggering the increase in motility; motility could be repeatedly evoked by C5a in nominally Ca(2+)-free solution, while Ca2+ signals occurred only upon the first stimulation. Moreover, conditions mimicking intracellular Ca2+ transients, like incubation with thapsigargin or Ca2+ ionophore A23187, were not able to induce any motility reaction, suggesting that Ca2+ transients are not necessary for, but are associated with, microglial motility. Motile activity was shown to be restricted to a defined concentration range of [Ca2+]i as revealed by lowering [Ca2+]i with BAPTA-AM or increasing [Ca2+]i with A23187. Since complement factors are released at pathological sites, this signal cascade could serve to increase motility and to direct microglial cells to the lesioned or damaged area by means of a G-protein-dependent pathway and via the rearrangement of the actin cytoskeleton.
Similar articles
- Extracellular acidification decreases the basal motility of cultured mouse microglia via the rearrangement of the actin cytoskeleton.
Faff L, Nolte C. Faff L, et al. Brain Res. 2000 Jan 17;853(1):22-31. doi: 10.1016/s0006-8993(99)02221-0. Brain Res. 2000. PMID: 10627304 - Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia.
Möller T, Nolte C, Burger R, Verkhratsky A, Kettenmann H. Möller T, et al. J Neurosci. 1997 Jan 15;17(2):615-24. doi: 10.1523/JNEUROSCI.17-02-00615.1997. J Neurosci. 1997. PMID: 8987784 Free PMC article. - Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia.
Ilschner S, Nolte C, Kettenmann H. Ilschner S, et al. Neuroscience. 1996 Aug;73(4):1109-20. doi: 10.1016/0306-4522(96)00107-8. Neuroscience. 1996. PMID: 8809828 - Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
Das R, Chinnathambi S. Das R, et al. Neuroscience. 2020 Nov 10;448:325-336. doi: 10.1016/j.neuroscience.2020.09.024. Epub 2020 Sep 14. Neuroscience. 2020. PMID: 32941933 Review. - G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia.
Chidambaram H, Das R, Chinnathambi S. Chidambaram H, et al. Eur J Cell Biol. 2022 Apr;101(2):151201. doi: 10.1016/j.ejcb.2022.151201. Epub 2022 Jan 25. Eur J Cell Biol. 2022. PMID: 35101770 Review.
Cited by
- Receptors on Microglia.
Augusto-Oliveira M, Tremblay MÈ, Verkhratsky A. Augusto-Oliveira M, et al. Adv Neurobiol. 2024;37:83-121. doi: 10.1007/978-3-031-55529-9_6. Adv Neurobiol. 2024. PMID: 39207688 Review. - Enhanced phagocytosis associated with multinucleated microglia via Pyk2 inhibition in an acute β-amyloid infusion model.
Lee JW, Mizuno K, Watanabe H, Lee IH, Tsumita T, Hida K, Yawaka Y, Kitagawa Y, Hasebe A, Iimura T, Kong SW. Lee JW, et al. J Neuroinflammation. 2024 Aug 6;21(1):196. doi: 10.1186/s12974-024-03192-7. J Neuroinflammation. 2024. PMID: 39107821 Free PMC article. - Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges.
Shui X, Chen J, Fu Z, Zhu H, Tao H, Li Z. Shui X, et al. J Inflamm Res. 2024 May 22;17:3335-3352. doi: 10.2147/JIR.S461795. eCollection 2024. J Inflamm Res. 2024. PMID: 38800598 Free PMC article. Review. - The Implications of Microglial Regulation in Neuroplasticity-Dependent Stroke Recovery.
Qiao C, Liu Z, Qie S. Qiao C, et al. Biomolecules. 2023 Mar 21;13(3):571. doi: 10.3390/biom13030571. Biomolecules. 2023. PMID: 36979506 Free PMC article. Review. - Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases.
Javed H, Mohamed Fizur NM, Jha NK, Ashraf GM, Ojha S. Javed H, et al. Curr Neuropharmacol. 2023;21(6):1421-1432. doi: 10.2174/1570159X21666221223120251. Curr Neuropharmacol. 2023. PMID: 36567278 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous